RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Pediatrix Medical Group Stock

Pediatrix Medical Group Revenue 2024

Pediatrix Medical Group Revenue

2.05 B USD

Ticker

MD

ISIN

US58502B1061

WKN

A0RELL

In 2024, Pediatrix Medical Group's sales reached 2.05 B USD, a 2.98% difference from the 1.99 B USD sales recorded in the previous year.

The Pediatrix Medical Group Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2027e2.3819,59
2026e2.0622,70
2025e2.0323,05
2024e2.0522,74
20231.9923,41
20221.9723,68
20211.9126,85
20201.7326,93
20191.7826,24
20181.7227,10
20173.2514,36
20163.1814,67
20152.7816,80
20142.4419,15
20132.1521,68
20121.8225,71
20111.5929,41
20101.433,32
20091.2936,25
20081.0743,72
20070.9250,90
20060.858,04
20050.6868,60
20040.6275,38

Pediatrix Medical Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Pediatrix Medical Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Pediatrix Medical Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Pediatrix Medical Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Pediatrix Medical Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Pediatrix Medical Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Pediatrix Medical Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Pediatrix Medical Group’s growth potential.

Pediatrix Medical Group Revenue, EBIT and net profit per share

DatePediatrix Medical Group RevenuePediatrix Medical Group EBITPediatrix Medical Group Net Income
2027e2.38 B undefined0 undefined108.79 M undefined
2026e2.06 B undefined177.11 M undefined131.12 M undefined
2025e2.03 B undefined170.13 M undefined127.1 M undefined
2024e2.05 B undefined164.67 M undefined112.77 M undefined
20231.99 B undefined157.85 M undefined-60.41 M undefined
20221.97 B undefined200 M undefined66.34 M undefined
20211.91 B undefined217.74 M undefined130.96 M undefined
20201.73 B undefined171.9 M undefined-796.5 M undefined
20191.78 B undefined232.7 M undefined-1.5 B undefined
20181.72 B undefined248.4 M undefined268.6 M undefined
20173.25 B undefined454.9 M undefined320.4 M undefined
20163.18 B undefined571.7 M undefined324.9 M undefined
20152.78 B undefined557.9 M undefined336.3 M undefined
20142.44 B undefined513 M undefined317.3 M undefined
20132.15 B undefined452.1 M undefined280.5 M undefined
20121.82 B undefined389.5 M undefined240.9 M undefined
20111.59 B undefined355.4 M undefined218 M undefined
20101.4 B undefined312.9 M undefined202.7 M undefined
20091.29 B undefined288.9 M undefined175.8 M undefined
20081.07 B undefined242 M undefined169.2 M undefined
2007917.6 M undefined220.9 M undefined142.7 M undefined
2006804.7 M undefined194.4 M undefined124.5 M undefined
2005680.8 M undefined142.9 M undefined87.5 M undefined
2004619.6 M undefined153.2 M undefined96.2 M undefined

Pediatrix Medical Group stock margins

The Pediatrix Medical Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pediatrix Medical Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pediatrix Medical Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Pediatrix Medical Group's sales revenue. A higher gross margin percentage indicates that the Pediatrix Medical Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Pediatrix Medical Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Pediatrix Medical Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Pediatrix Medical Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Pediatrix Medical Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Pediatrix Medical Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Pediatrix Medical Group Margin History

Pediatrix Medical Group Gross marginPediatrix Medical Group Profit marginPediatrix Medical Group EBIT marginPediatrix Medical Group Profit margin
2027e23.68 %0 %4.56 %
2026e23.68 %8.61 %6.37 %
2025e23.68 %8.4 %6.27 %
2024e23.68 %8.02 %5.49 %
202323.68 %7.91 %-3.03 %
202223.68 %10.14 %3.36 %
202126.85 %11.39 %6.85 %
202023.68 %9.91 %-45.93 %
201923.68 %13.07 %-84.15 %
201823.68 %14.42 %15.59 %
201723.68 %13.98 %9.85 %
201623.68 %17.96 %10.21 %
201523.68 %20.07 %12.1 %
201423.68 %21.03 %13.01 %
201323.68 %20.99 %13.02 %
201223.68 %21.44 %13.26 %
201123.68 %22.38 %13.73 %
201023.68 %22.32 %14.46 %
200923.68 %22.42 %13.65 %
200823.68 %22.65 %15.84 %
200723.68 %24.07 %15.55 %
200623.68 %24.16 %15.47 %
200523.68 %20.99 %12.85 %
200423.68 %24.73 %15.53 %

Pediatrix Medical Group Aktienanalyse

What does Pediatrix Medical Group do?

MEDNAX Inc. is an American company that provides medical services for newborns, children, and adults. The company was founded in 1979 in Florida and is headquartered in Sunrise, Florida. It is listed on the New York Stock Exchange and has an annual revenue of approximately $3.5 billion. MEDNAX's business model is to offer specialized medical services for newborns, children, and adults in hospitals, emergency rooms, and medical practices in the United States. The company operates a vertically integrated management structure that covers all aspects of healthcare, from clinical management to billing and coding. MEDNAX specializes in a wide range of specialties such as anesthesia, pediatrics, neonatology, intensive care, cardiology, radiology, and pathology. The company's history began in 1979 in Florida with the founding of the American Anesthesiology Practice (AAP). AAP has become a leading anesthesia service provider in Florida, serving hospitals, surgeons, and patients. In 1995, MEDNAX established the Florida Neonatology Practice (FNP) to provide specialized treatments for premature and sick newborns. In 2008, the company officially changed its name to MEDNAX. MEDNAX expanded through acquisitions of companies and practices. In 2010, MEDNAX acquired Pediatrix Medical Group, a leading provider of medical services for newborns, pregnant women, and women with high-risk pregnancies. In 2013, the company acquired Sheridan Healthcare, a market leader in anesthesia, radiology, and emergency medicine. In 2017, the company launched a new division in cardiology and acquired CardioSolutions, a company specializing in cardiac procedures. MEDNAX offers a wide range of medical services, divided into different divisions. These include neonatology, pediatrics, anesthesia, radiology, and pathology. The company also offers various products and services tailored to the specific needs of patients and physicians in the United States, such as cardiac services, coding and billing services, anesthesia devices, and preterm birth screening tests. Overall, MEDNAX is a leading provider of medical services in the United States, with a diverse range of specialties and services, and a growing presence through acquisitions. Pediatrix Medical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Pediatrix Medical Group's Sales Figures

The sales figures of Pediatrix Medical Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Pediatrix Medical Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Pediatrix Medical Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Pediatrix Medical Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Pediatrix Medical Group stock

How much revenue did Pediatrix Medical Group generate this year?

Pediatrix Medical Group has achieved a revenue of 2.05 B USD this year.

How much was the turnover of the company Pediatrix Medical Group compared to the previous year?

The revenue of Pediatrix Medical Group has increased by 2.98% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Pediatrix Medical Group?

The revenue of Pediatrix Medical Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Pediatrix Medical Group measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Pediatrix Medical Group so important for investors?

The revenue of Pediatrix Medical Group is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Pediatrix Medical Group pay?

Over the past 12 months, Pediatrix Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pediatrix Medical Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Pediatrix Medical Group?

The current dividend yield of Pediatrix Medical Group is .

When does Pediatrix Medical Group pay dividends?

Pediatrix Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pediatrix Medical Group?

Pediatrix Medical Group paid dividends every year for the past 0 years.

What is the dividend of Pediatrix Medical Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pediatrix Medical Group located?

Pediatrix Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pediatrix Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pediatrix Medical Group from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Pediatrix Medical Group pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Pediatrix Medical Group in the year 2023?

In the year 2023, Pediatrix Medical Group distributed 0 USD as dividends.

In which currency does Pediatrix Medical Group pay out the dividend?

The dividends of Pediatrix Medical Group are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Pediatrix Medical Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Pediatrix Medical Group

Our stock analysis for Pediatrix Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pediatrix Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.